Search

Your search keyword '"Ophthalmic agents -- Ethical aspects"' showing total 1 results
Start Over Descriptor "Ophthalmic agents -- Ethical aspects"
1 results on '"Ophthalmic agents -- Ethical aspects"'

1. Bevacizumab for eye diseases - Legal, regulatory, and ethical overview

Author

Jose, Vinu, Radhakrishna, Swetha, Pipalava, Parag, and Singh, Inderjeet

Subjects
United States. Food and Drug Administration -- Ethical aspects, Cancer treatment, Ophthalmic agents -- Ethical aspects, Ramucirumab, Bevacizumab -- Ethical aspects, Vascular endothelial growth factor, Eye diseases, Pegaptanib, Endothelium, Angiogenesis inhibitors, Endothelial growth factors, Aflibercept, Ranibizumab, Diseases, Health
Abstract

Byline: Vinu. Jose, Swetha. Radhakrishna, Parag. Pipalava, Inderjeet. Singh Vascular endothelial growth factor (VEGF) inhibitors, ranibizumab, aflibercept, and pegaptanib are approved treatments for certain eye diseases that occurs especially in [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results